Pharmaceutical Research最新文献

筛选
英文 中文
Generative AI-Designed Immunoglobulin Domain Antibodies (IgDAbs) Against the Fusion Protein as a Neutralizing Agent for Respiratory Syncytial Virus. 生成ai设计的抗融合蛋白免疫球蛋白结构域抗体(IgDAbs)作为呼吸道合胞病毒的中和剂。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-13 DOI: 10.1007/s11095-026-04226-w
Yenisetti Rajendra Prasad, Prakash Y Khandave, Mihir Ratnaparkhe, Akash G Kendre, Prasad V Bharatam, Abhay H Pande
{"title":"Generative AI-Designed Immunoglobulin Domain Antibodies (IgDAbs) Against the Fusion Protein as a Neutralizing Agent for Respiratory Syncytial Virus.","authors":"Yenisetti Rajendra Prasad, Prakash Y Khandave, Mihir Ratnaparkhe, Akash G Kendre, Prasad V Bharatam, Abhay H Pande","doi":"10.1007/s11095-026-04226-w","DOIUrl":"https://doi.org/10.1007/s11095-026-04226-w","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to rationally design, screen, and experimentally validate novel immunoglobulin domain antibodies (IgDAbs) targeting the site II epitope of the respiratory syncytial virus (RSV) fusion (F) protein using generative artificial intelligence (GenAI) driven tools.</p><p><strong>Method: </strong>A generative AI tool was employed to generate 250 novel IgDAb sequences optimized for RSV-F site II binding. Candidates were screened computationally using molecular docking and molecular dynamics simulations to select hit candidates. The selected IgDAbs were cloned and produced using an E. coli expression system. Purified IgDAbs were characterized for target specificity via ELISA and evaluated for functional viral inhibition using in vitro microneutralization assay against RSV A2 (long strain).</p><p><strong>Result: </strong>Computational screening narrowed the library to 05 structurally compatible hit IgDAb with predicted binding affinity. ELISA confirmed specific binding of purified IgDAbs to the RSV-F protein. In vitro microneutralization assays demonstrated neutralization of RSV A2 (long strain), with two 'lead' IgDAbs showing EC<sub>50</sub> of 1.3 µg/mL and 3.5 µg/mL.</p><p><strong>Conclusion: </strong>Combining generative AI sequence generation with an integrated in silico and in vitro screening cascade enables the rapid, cost-effective discovery of neutralizing nanobodies against RSV, offering a viable alternative to resource-intensive traditional antibody discovery workflows.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lysozyme Hydrogel Microneedles for Enhanced Burn Wound Healing. 促进烧伤伤口愈合的溶菌酶水凝胶微针。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-12 DOI: 10.1007/s11095-026-04214-0
Qi Zong, Renhang Zhou, Bowen Li, Zijie Zhao, Xiaofei Zhang, Wenzhuo Li, Ao Li, Yunlu Ning, Chao Sheng, Zhixiang Zhou
{"title":"Lysozyme Hydrogel Microneedles for Enhanced Burn Wound Healing.","authors":"Qi Zong, Renhang Zhou, Bowen Li, Zijie Zhao, Xiaofei Zhang, Wenzhuo Li, Ao Li, Yunlu Ning, Chao Sheng, Zhixiang Zhou","doi":"10.1007/s11095-026-04214-0","DOIUrl":"https://doi.org/10.1007/s11095-026-04214-0","url":null,"abstract":"<p><strong>Purpose: </strong>To reduce the inconvenience of medication for patients during burn wound healing, developing a novel drug delivery system is highly significant. In this study, we developed lysozyme-loaded hydrogel microneedles incorporating methacrylated hyaluronic acid (HAMA) into the needle matrix.</p><p><strong>Methods: </strong>We observed the morphological structure of the microneedles using a stereomicroscope and a scanning electron microscope, and characterized the materials by means of X-ray diffraction (XRD), infrared spectroscopy and Differential scanning calorimetry (DSC). Furthermore, the in vitro release and in vitro antibacterial ability of the lysozyme hydrogel microneedles were studied. Finally, the application of these microneedles in the healing of animal burn wounds was carried out.</p><p><strong>Results: </strong>Upon subcutaneous application, the hydrogel interacts with the tissue and gradually releases lysozyme. Compared with traditional topical application drug delivery, these microneedles demonstrate higher subcutaneous penetration efficiency and a sustained-release profile. In vivo experiments on burn wound healing further confirmed that the lysozyme hydrogel microneedles significantly enhance the healing process.</p><p><strong>Conclusions: </strong>The designed microneedles are both convenient and efficient, offering a promising new approach for burn wound treatment.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inline Raman Spectroscopy as a Process Analytical Technology Tool for Real-Time Concentration Monitoring and Mixing Endpoint Determination of an Oligonucleotide Drug Product. 在线拉曼光谱作为一种过程分析技术工具,用于低核苷酸药物产品的实时浓度监测和混合终点测定。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-12 DOI: 10.1007/s11095-026-04232-y
Francis Kwofie, Parind M Desai, Stephanie Williams, Anderson McLeod
{"title":"Inline Raman Spectroscopy as a Process Analytical Technology Tool for Real-Time Concentration Monitoring and Mixing Endpoint Determination of an Oligonucleotide Drug Product.","authors":"Francis Kwofie, Parind M Desai, Stephanie Williams, Anderson McLeod","doi":"10.1007/s11095-026-04232-y","DOIUrl":"https://doi.org/10.1007/s11095-026-04232-y","url":null,"abstract":"<p><strong>Background: </strong>Oligonucleotide drug product manufacturing commonly relies on time-consuming offline ultraviolet-visible (UV-Vis) spectroscopy and high-performance liquid chromatography (HPLC) analyses to confirm active pharmaceutical ingredient (API) concentration during mixing, providing limited process visibility. This study evaluated inline Raman spectroscopy as a process analytical technology (PAT) tool for real-time API concentration monitoring and mixing endpoint determination during manufacture of a model antisense oligonucleotide (ASO) drug product.</p><p><strong>Methods: </strong>A partial least squares regression (PLSR) model was developed from inline Raman spectra using offline UV-Vis reference concentrations. Accuracy, linearity, range, precision, specificity, and robustness were evaluated, including effects of stirring speed, probe depth, and reusable versus single-use Raman optics. The validated model was applied to four ASO drug product batches manufactured in a 50-L single-use mixer.</p><p><strong>Results: </strong>The PLSR model demonstrated good accuracy (RMSEP = 3.47 mg/mL), good linearity (R<sup>2</sup> = 0.994 and 0.996 for calibration and independent prediction set, respectively), and precision (maximum %RSD = 1.12%). Minimal water interference supported specificity, and consistent performance across stirring speeds, probe depths, and Raman optic configurations demonstrated robustness. The procedure generated real-time ASO API concentration profiles and successfully determined the mixing endpoint for all four batches.</p><p><strong>Conclusions: </strong>Inline Raman spectroscopy coupled with PLSR provided accurate, specific, and robust real-time API concentration monitoring during oligonucleotide drug product manufacturing. The approach enabled real-time monitoring and objective mixing endpoint determination and may reduce reliance on offline measurements while improving process visibility and supporting more timely progression of manufacturing operations.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study. 受体靶向序贯噬菌体给药抗铜绿假单胞菌PAO1:体外概念验证研究
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-09 DOI: 10.1007/s11095-026-04207-z
Mengyu Li, Yue Cao, Rachel Yoon Kyung Chang, Dipesh Khanal, Sandra Morales, Hee-Won Bae, You-Hee Cho, Hak-Kim Chan
{"title":"Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study.","authors":"Mengyu Li, Yue Cao, Rachel Yoon Kyung Chang, Dipesh Khanal, Sandra Morales, Hee-Won Bae, You-Hee Cho, Hak-Kim Chan","doi":"10.1007/s11095-026-04207-z","DOIUrl":"https://doi.org/10.1007/s11095-026-04207-z","url":null,"abstract":"<p><strong>Purpose: </strong>Antibiotic resistance has intensified the need for alternative therapies, such as bacteriophage administration. However, the optimal delivery strategy-specifically simultaneous versus sequential dosing-remains poorly defined for ensuring sustainable efficacy. This single-strain, in vitro proof-of-concept study evaluated receptor-targeted sequential dosing using phages Dobby, targeting lipopolysaccharide, and MPK7, targeting type IV pili, against P. aeruginosa PAO1.</p><p><strong>Methods: </strong>Time-kill assays were conducted at various multiplicities of infection (MOI: 0.01, 1, and 100) to compare simultaneous and sequential dosing regimens. Resistance profiling was performed to assess the fitness costs of resulting isolates, while atomic force microscopy infrared spectroscopy (AFM-IR) was utilized to identify chemical signatures and underlying resistance mechanisms in phage-resistant mutants.</p><p><strong>Results: </strong>Sequential treatment, particularly initiating therapy with the LPS-specific phage Dobby followed by MPK7, was more effective than simultaneous dosing, achieving bacterial reductions exceeding 3-log10 within 48 h. Notably, low MOI (0.01) sequential treatments maintained sustained population suppression, whereas high MOI (100) treatments triggered rapid bacterial rebound. Resistance profiling confirmed that Dobby-resistant isolates exhibited lower fitness costs, rendering them more susceptible to subsequent MPK7 treatment. AFM-IR revealed unique chemical alterations in resistant mutants, specifically linked to LPS truncation and TFP dysfunction.</p><p><strong>Conclusions: </strong>In the Dobby-MPK7-PAO1 model, receptor-specific sequential dosing produced more sustained bacterial suppression than simultaneous treatment. This proof-of-concept supports further evaluation of temporal phage dosing across diverse P. aeruginosa strains and phage combinations.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149380072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transdermal Acetaminophen and Caffeine for Migraine, Part 1: Solid Microneedles and Co-loaded Polymeric Gels. 偏头痛的经皮对乙酰氨基酚和咖啡因,第1部分:固体微针和共负载聚合物凝胶。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-09 DOI: 10.1007/s11095-026-04234-w
Harsha Jain, Nicole K Brogden
{"title":"Transdermal Acetaminophen and Caffeine for Migraine, Part 1: Solid Microneedles and Co-loaded Polymeric Gels.","authors":"Harsha Jain, Nicole K Brogden","doi":"10.1007/s11095-026-04234-w","DOIUrl":"https://doi.org/10.1007/s11095-026-04234-w","url":null,"abstract":"<p><strong>Purpose: </strong>Acetaminophen (ACM) and caffeine (CAF) are frequently co‑administered for rapid analgesic relief for migraines, and transdermal delivery of these over-the-counter therapies could improve the patient at-home experience. In this 2-part series we examine the impact of formulation and physical enhancements on ACM and CAF skin transport. Here in part 1, we examined how polymer and solid microneedle pretreatment influence ACM and CAF release and dermal permeation from hydroxyethyl cellulose and polyvinylpyrrolidone gels. Part 2 examines impacts of dissolving microneedles and applied heat.</p><p><strong>Methods: </strong>FTIR was used to assess potential interactions between the active pharmaceutical ingredients (APIs) and polymers. Viscosity and viscoelastic parameters (G' and G″) of the polymeric gels were measured on a rheometer. Diffusion studies were performed to quantify API release and permeation through dermatomed porcine skin, from single or dual-API loaded gels. Transepidermal water loss (TEWL) studies measured skin barrier disruption after microneedle application.</p><p><strong>Results: </strong>FTIR confirmed that both drugs remained chemically unchanged in each polymer matrix, indicating no strong drug-polymer interactions. Microneedle pretreatment significantly enhanced permeation for all formulations, with varying levels of enhancement for individual vs co‑API gels. Impact of co-delivery on permeation was dependent on API, polymer, and timing.</p><p><strong>Conclusions: </strong>Polymer structure, co-delivery, and microchannel‑mediated transport all influenced ACM and CAF delivery across intact and solid microneedle-treated skin.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149380073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opening the Black Box: How Agentic AI-Assisted Modeling Lets Pharmacometricians See Inside NONMEM. 打开黑匣子:人工智能辅助建模如何让药物计量学家看到NONMEM的内部。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-02 DOI: 10.1007/s11095-026-04231-z
Yiming Cheng, Yan Li
{"title":"Opening the Black Box: How Agentic AI-Assisted Modeling Lets Pharmacometricians See Inside NONMEM.","authors":"Yiming Cheng, Yan Li","doi":"10.1007/s11095-026-04231-z","DOIUrl":"https://doi.org/10.1007/s11095-026-04231-z","url":null,"abstract":"<p><p>NONMEM is the gold-standard tool in pharmacometrics, yet much of its estimation engine operates out of sight. Routine outputs show what the engine reports, but not everything it computes along the way. The quantities needed to answer a specific question may exist transiently within the long-established Fortran-based engine, but for most modelers they remain hidden behind an implementation barrier. AI-assisted modeling changes that barrier. A user can pose a question in \"vibe\" language, work with an AI assistant to generate verbatim Fortran code that instruments the running engine and exposes otherwise unavailable quantities on demand for use as additional model diagnostics or in other ad hoc investigations. We illustrate this capability with two examples: capturing how subject-level samples evolve from one iteration to the next during NONMEM's expectation-maximization (EM) methods, including importance sampling (IMP) and stochastic approximation expectation maximization (SAEM), and tracking the BFGS Hessian approximation and objective-function gradients across snapshots of first-order conditional estimation (FOCE). The examples themselves are not the central contribution. Rather, they demonstrate how AI can turn NONMEM from a closed black box into an engine that motivated users can interrogate when new questions arise. When paired with scientific judgment and numerical verification, AI can make forms of engine-level inspection once largely limited to developers and specialized experts accessible to everyday modelers, substantially shortening the distance between a NONMEM user and a NONMEM expert.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Aqueous and Lyophilized Formulations for LBURGINAZE™. LBURGINAZE™水和冻干制剂的开发。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-11-02 DOI: 10.1007/s11095-026-04230-0
Yenisetti Rajendra Prasad, Abhay H Pande
{"title":"Development of Aqueous and Lyophilized Formulations for LBURGINAZE™.","authors":"Yenisetti Rajendra Prasad, Abhay H Pande","doi":"10.1007/s11095-026-04230-0","DOIUrl":"https://doi.org/10.1007/s11095-026-04230-0","url":null,"abstract":"<p><strong>Background: </strong>LBURGINAZE™ is an engineered human arginase-1 fusion protein developed to exploit tumor metabolic vulnerabilities via systemic arginine depletion. Developing a stable formulation is necessary to preserve its enzymatic activity during long-term storage and clinical translation. Thus, this study aimed to systematically screen excipients and rationally develop aqueous and lyophilized formulations of LBURGINAZE.</p><p><strong>Method: </strong>A panel of pharmaceutically acceptable excipients, including sugars, polyols, and amino acids, was screened under thermal stress at 25℃ by measuring arginine hydrolytic activity. Formulations were evaluated in both liquid and freeze-dried states, with lead single excipients that preserved catalytic activity subsequently incorporated into multi-component formulations. Following stability assessments, the biological potency of reconstituted LBURGINAZE was evaluated against 3D HepG2 hepatocellular carcinoma spheroids alone and in combination with the multi-kinase inhibitor sorafenib.</p><p><strong>Results: </strong>In aqueous state, a multi-component formulation containing glycerol, L-alanine, NaCl, and polysorbate 80 provided optimal stability, preserving catalytic activity over 4 weeks. For solid-state storage, a single-excipient lyophilization containing sucrose provided superior lyoprotection, effectively maintaining 100% of arginine hydrolytic activity across 90 days at 25℃. Upon reconstitution, LBURGINAZE retained potent, concentration-dependent anti-proliferative efficacy against HepG2 3D tumor spheroids (IC<sub>50</sub> = 5.49 µg/mL) and displayed strong pharmacological synergism when combined with sorafenib.</p><p><strong>Conclusion: </strong>These rational formulation approaches provide strong stability for LBURGINAZE™ in both aqueous and solid states at ambient conditions, providing a scalable platform to support its ongoing preclinical development.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Modeling and Simulation Approach to Predicting Oral Absorption of a Weakly Basic Drug: Impact of Acid-Reducing Agents and Storage-Induced Increases in Free Drug Form. 预测弱碱性药物口服吸收的建模和模拟方法:酸还原剂的影响和储存诱导的游离药物形态的增加。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-10-28 DOI: 10.1007/s11095-026-04218-w
Yuki Ando, Tsuyoshi Kiyota, Ryoshi Iwaki, Brian C Ferslew, Tomohiro Asai, Atsushi Kambayashi
{"title":"A Modeling and Simulation Approach to Predicting Oral Absorption of a Weakly Basic Drug: Impact of Acid-Reducing Agents and Storage-Induced Increases in Free Drug Form.","authors":"Yuki Ando, Tsuyoshi Kiyota, Ryoshi Iwaki, Brian C Ferslew, Tomohiro Asai, Atsushi Kambayashi","doi":"10.1007/s11095-026-04218-w","DOIUrl":"https://doi.org/10.1007/s11095-026-04218-w","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to develop a simulation model to predict the effect of gastric pH on human oral absorption of solid oral formulations containing a weakly basic drug which accounted for increases in the free drug form during tablet storage.</p><p><strong>Methods: </strong>We evaluated the in vitro solubility, permeability, and precipitation behavior of a compound and constructed a simulation model based on the experimental data. The predictive performance of the model was verified using clinical data from healthy volunteers administered capsules (prediction errors within ± 19%), which demonstrated sufficient accuracy in predicting human absorption. In addition, the effect of gastric pH on human absorption after oral administration was predicted for tablet formulations before storage (with free drug form levels below the analytical detection limit) and after storage (with increased free drug form levels).</p><p><strong>Results: </strong>The simulation results indicated that the absorption of tablets with increased free drug content was significantly reduced under elevated gastric pH conditions. The model successfully reproduced the decreased plasma concentrations observed in subjects receiving acid-reducing agents (ARAs) compared with those not receiving ARAs in a clinical study. The observed and predicted plasma concentration ratios were 0.14 and 0.25, respectively.</p><p><strong>Conclusions: </strong>Overall, this simulation model provides a practical approach for predicting gastric pH-dependent oral absorption while accounting for storage-induced changes in free drug form, and will contribute to more efficient formulation design and clinical development.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149299704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identity Testing of Biopharmaceuticals using Nano-Differential-Scanning-Fluorimetry. 纳米差示扫描荧光法鉴别生物药品。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-10-27 DOI: 10.1007/s11095-026-04220-2
Elisabeth Fakler, Steffen Kiessig, Hanns-Christian Mahler, Andrea Allmendinger
{"title":"Identity Testing of Biopharmaceuticals using Nano-Differential-Scanning-Fluorimetry.","authors":"Elisabeth Fakler, Steffen Kiessig, Hanns-Christian Mahler, Andrea Allmendinger","doi":"10.1007/s11095-026-04220-2","DOIUrl":"https://doi.org/10.1007/s11095-026-04220-2","url":null,"abstract":"<p><strong>Purpose: </strong>Identity (ID) testing is an integral part of the analytical control strategy of biopharmaceutical products confirming the ID of both drug substances (DS) before starting the fill-finish process as well as of the finished drug product (DP). Common methods for ID testing, including liquid chromatography-mass spectrometry and immunoassays, often involve time-intensive workflows and demanding data analysis, creating challenges and added complexity for routine quality control ID testing.</p><p><strong>Methods: </strong>This study evaluated a novel ID testing approach using nano-scale differential scanning fluorimetry (nanoDSF), which measures intrinsic protein fluorescence during thermal unfolding. Multiple data analysis strategies were evaluated, including single-point, curve correlation, and squared Euclidean distance (ED<sup>2</sup>) analyses.</p><p><strong>Results: </strong>A panel of fifteen biopharmaceutical products was tested representing diverse molecular formats. Method performance was assessed using confusion matrices comparing samples to reference profiles. The ED<sup>2</sup> metric (threshold 0.006) demonstrated strongest performance, achieving 100% specificity and 99.7% sensitivity across the product panel excluding biosimilars.</p><p><strong>Conclusion: </strong>The nanoDSF method's robustness and rapid turnaround time support its suitability as an ID test for facilities handling multiple products and diverse product types. The selected data analysis approach does not require generation of statistical models enabling simplified method validation and implementation in QC.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149287992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation Development and Characterization of Ibrutinib-Loaded Liposomes with Molecular Dynamics Insights. 依鲁替尼负载脂质体的分子动力学研究。
IF 4.1 3区 医学
Pharmaceutical Research Pub Date : 2026-10-26 DOI: 10.1007/s11095-026-04229-7
Xiufang Cheng, Rijo John, Jasmin Monpara, Pardeep Gupta
{"title":"Formulation Development and Characterization of Ibrutinib-Loaded Liposomes with Molecular Dynamics Insights.","authors":"Xiufang Cheng, Rijo John, Jasmin Monpara, Pardeep Gupta","doi":"10.1007/s11095-026-04229-7","DOIUrl":"https://doi.org/10.1007/s11095-026-04229-7","url":null,"abstract":"<p><strong>Purpose: </strong>This study explored the integration of molecular dynamics (MD) simulations with experimental formulation development toward the rational design of liposomal drug delivery systems using Ibrutinib as model drug. The simulation served as a computationally informed, mechanistically supportive component to aid interpretation of empirical formulation data.</p><p><strong>Methods: </strong>Atomistic MD simulations were used to evaluate drug-lipid miscibility, guide lipid selection and inform the drug-loading method. Ibrutinib-loaded liposomes were prepared using a charge-assisted loading method and optimized through Design of Experiments (DOE). Physicochemical characterization included particle size, zeta potential, encapsulation efficiency, morphology, and in vitro drug release. Coarse-grained (CG) MD simulations were performed to investigate liposome self-assembly, drug localization, and PEGylation effects.</p><p><strong>Results: </strong>MD simulations predicted favorable miscibility between Ibrutinib and neutral phospholipids, supporting formulation design by the selection of phospholipid and drug-loading method. DOE optimization identified formulation and process parameters associated with high efficiency (> 90%) and nanoscale particle size. Experimental studies showed that lipid composition and PEGylation influenced liposome drug release behavior. CG simulations reproduced liposome self-assembly and suggested preferential localization of Ibrutinib near the lipid-water interface, consistent with charge-based interactions between the lipid and drug.</p><p><strong>Conclusion: </strong>The combined computational and experimental approach provided complementary molecular-level insights into liposome formulation behavior. Although the simulations did not predict quantitative outcomes, they offered mechanistic context that supported empirical findings. This approach demonstrated the potential utility of integrating MD simulations with experimental studies during early-stage formulation development.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149272149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书